Filing summary
Registrant identity: The supplied filing is for AlphaVest Acquisition Corp, not AMC Robotics Corp as stated in the request metadata. It is a SPAC incorporated to pursue a business combination.
Reporting period: Form 10-Q for the quarter ended June 30, 2023, filed August 11, 2023. The financial statements also report six-month results through June 30, 2023.
Financial performance and position
| Metric | Reported amount |
|---|---|
| Q2 2023 net income | $704,556 |
| Q2 2023 trust and bank interest income | $834,743 |
| Q2 2023 formation and operating costs | $130,187 |
| Six-month 2023 net income | $1,349,454 |
| Six-month 2023 trust and bank interest income | $1,637,827 |
| Six-month 2023 formation and operating costs | $288,373 |
| Operating revenue | None; the company reports no operations or operating revenue before a business combination. |
| Cash used in operating activities, six months | $438,236 |
| Cash at June 30, 2023 | $220,799 |
| Trust investments at June 30, 2023 | $72,055,901 |
| Total assets at June 30, 2023 | $72,343,270 |
| Current liabilities at June 30, 2023 | $59,273 |
| Shareholders’ equity at June 30, 2023 | $228,096 |
| Debt | No long-term debt reported; the related-party promissory note had no outstanding balance and expired. |
Trust-account funds are largely earmarked for a business combination or shareholder redemptions and are not generally available for operating expenses. The company reported no margins; operating revenue had not begun.
Changes versus prior period
- Cash declined from $659,035 at December 31, 2022 to $220,799 at June 30, 2023, primarily reflecting operating cash use.
- Trust investments increased from $70,418,228 to $72,055,901, with interest driving the increase. Redeemable shares’ carrying value rose from $70.38 million to $72.06 million.
- The six-month 2023 net income contrasts with a $3,749 net loss from inception through June 30, 2022. The 2022 period was pre-IPO and is not a like-for-like operating comparison.
Outlook, risks and unusual items
- Management is searching for a target and expects continued public-company and due-diligence costs. No specific target, business-combination guidance, or operating forecast is provided in the supplied filing text.
- The company has 12 months from the IPO closing to complete a business combination, or 18 months if extended. Management states there is no assurance it will complete a transaction within the permitted period and discloses substantial doubt about its ability to continue as a going concern within one year after issuance of the financial statements. Failure to complete a transaction would lead to winding up and redemption of public shares, subject to the filing’s terms.
- Disclosure controls were deemed ineffective due to a material weakness related to the accretion adjustment for redeemable shares. Management performed additional analysis and stated that the financial statements fairly present the company’s position and results.
- Potential transaction costs include a $2.415 million business-combination marketing fee to EBC upon closing, plus a possible fee equal to 1% of transaction consideration if EBC introduces the target. The company also pays $10,000 monthly for administrative services until a combination or liquidation.
- Management noted that COVID-19 could adversely affect the company or its target search, but the impact was not readily determinable. The filing reports no legal proceedings and no material changes to previously disclosed risk factors.
Important facts for investors to verify
- Confirm the intended issuer: the filing identifies AlphaVest Acquisition Corp, not AMC Robotics Corp.
- Check the business-combination deadline, any extension, and the status of the target search; the filing does not identify a completed transaction.
- Distinguish trust-account assets from cash available for operations, and review redemption levels and any need for additional financing.
- Review remediation of the material weakness and the accounting for accretion of redeemable shares.
- Verify the terms and potential effect of EBC fees, redemption rights, and liquidation provisions on public shareholders.